West Asia shadow on exports
The article highlights the challenges arising for the pharmaceutical and preventive healthcare sector due to the West Asia crisis, particularly through disruptions in trade routes, rising logistics and freight costs, shipment delays, and uncertainty in exports. It further underscores the need for resilient supply chains, diversification of export markets, alternative shipping strategies, and stronger policy support to help the sector navigate geopolitical and trade-related disruptions.
India’s policy needs execution, not mere formulation
This opinion piece examines the challenges facing India’s nutraceutical sector, particularly gaps in categorisation, approval timelines, and scientific infrastructure. It further outlines recommendations such as evidence-based claim categorisation, introduction of a credible “Nutra Mark” certification, and clearer regulatory ownership between FSSAI and CDSCO. The piece also stresses the importance of stronger scientific infrastructure and strategic export planning to accelerate sectoral growth.
Sustainable sourcing for nutraceuticals: Creating enduring systems
The featured article explores the best practices of sustainable sourcing in the nutraceutical sector and at OmniActive Health Technologies as demand for natural ingredients continues to rise. It emphasizes responsible cultivation, efficient resource utilization, stronger farmer collaboration, and scientific validation to build resilient supply chains. The piece further underlines how sustainability is moving beyond compliance to become integral to nutraceutical innovation and long-term industry growth.
Nutraceutical exports to US impacted by tariffs says Sanjaya Mariwala
The article discusses how tariff uncertainties disrupted US-bound nutraceutical exports, prompting inventory corrections and caution among buyers, while underscoring the need for stable trade policies.
Labour codes can revive workforce and industry, but gaps remain
The article examines how new labour codes could improve flexibility and productivity, while noting implementation challenges and unresolved concerns that require balanced policy attention.
Union Budget 2025 Inaugurating a new era of growth and development
The analysis positions Budget 2025 as a catalyst for economic acceleration, focusing on infrastructure, reforms, and sectoral support to drive sustained and inclusive growth.
OmniActive scouts for acquisitions to expand product portfolio and reach
OmniActive Health Technologies is pursuing strategic acquisitions to diversify its product range, strengthen its market presence, and accelerate growth. The company is leveraging its R&D, integrated supply chain, and regulatory-compliant facilities to reinforce leadership in the nutraceutical sector.
India enjoys natural advantage in the nutraceutical sector
In an exclusive interaction, Mr. Sanjaya Mariwala delved deep into the world of health and nutraceuticals, exploring the innovative strategies behind OmniActive’s success in India and international markets.
Manufacturing Sector needs transformative push
Mr. Sanjaya Mariwala shares his thoughts in The Hindu Business Line on the transformative policy reset India’s manufacturing sector needs. The article outlines recommendations to redefine medium enterprises, strengthen skilling, boost R&D, support MSMEs, and foster entrepreneurship—building a globally competitive, inclusive, and innovation-led manufacturing ecosystem.
A healthy prescription
Mr. Sanjaya Mariwala discussed the critical role of private-sector innovation as a growth driver in the booming nutraceutical industry. He also shared his insights on how private companies likeOmniActive Health Technologiesare leading advancements in R&D, despite challenges and the need for policy support. Further, he discussed on how the Indian government could enhance its recognition of private-sector contributions, going beyond a public-sector focus to foster a more collaborative innovation ecosystem.
West Asia Crisis Puts India’s Pharma and Preventive Healthcare Exports to the Test
This opinion piece examines how the West Asia crisis is testing India’s pharmaceutical and preventive healthcare exports through rising freight costs, supply chain disruptions, shipment delays, and trade uncertainties. It further discusses the need for resilient supply chains, diversified sourcing strategies, alternative trade routes, and stronger policy support to help the sector manage geopolitical disruptions and sustain export competitiveness in global markets.
India-US deal brings relief to nutraceutical exports after customers cut orders and inventories
The interim India-US trade deal lowers tariffs, restores exporter confidence, and emphasises policy clarity and stable frameworks to revive nutraceutical orders and enable long-term investment planning.
From Budget Vision to Manufacturing Momentum
The article explores how policy direction must translate into on-ground manufacturing strength, urging sharper execution, innovation focus, and industry-government alignment to unlock India’s growth potential.
Reimagining the Union Budget Turning an Annual Ritual into a Strategic Roadmap
The piece argues that the Union Budget should move beyond yearly announcements and become a long-term strategic framework guiding investment, competitiveness, and inclusive economic transformation.
India’s nutraceutical moment needs structure not just scale
India’s nutraceutical sector stands at a pivotal moment, where scaling production must be matched with regulatory clarity, quality benchmarks, and scientific validation to ensure sustainable global growth.
ABS reform is missing link in India’s plant-based innovation story
In an exclusive interview, Mr. Sanjaya Mariwala explains why reforming Access and Benefit Sharing regulations is vital to unlock plant-based research and responsible commercialization.
Turning tariff friction into a growth opportunity for India
The piece argues that US tariff distortions on Indian nutraceuticals highlight classification issues but also a chance for India to seize global demand and lead in preventive wellness exports.
How informed consumers are changing India’s nutraceutical landscape
Consumers’ growing health awareness and demand for transparency are reshaping India’s nutraceutical sector, pushing brands toward science-backed, personalised, and trust-driven offerings
A Budget of Continuity and Confidence: Key to India’s Global Aspirations
India’s Union Budget 2025-26 must balance continuity with targeted reforms to drive growth. Mr. Sanjaya Mariwala highlights how policy stability, improved governance, and strategic initiatives can strengthen investor confidence, boost industrial growth, and accelerate India’s journey toward a multi-trillion-dollar economy.
Union Budget 2025: A Booster Shot or Just a Band-Aid for Healthcare?
The Union Budget 2025-26 has introduced measures aimed at strengthening India’s healthcare sector, including investments in medical education, digital health, and preventive care. Mr. Sanjaya Mariwala, President of IMC Chamber of Commerce and Industry, notes that while these initiatives are positive steps, they may not fully address the systemic challenges facing the healthcare system. He emphasises that increased funding, structural reforms, and long-term policy focus are essential to build a more resilient and equitable healthcare infrastructure.
Unlocking the Future of India’s Nutraceutical Industry
India’s nutraceutical sector is poised for transformative growth, with the market expected to exceed US$100 billion by 2047. Achieving this potential will require stronger regulations, robust innovation, and greater consumer awareness. Mr. Sanjaya Mariwala, Executive Chairman and Managing Director of OmniActive Health Technologies, emphasises that strategic collaboration between government and industry players will be key to building a sustainable and competitive nutraceutical ecosystem.
Rethinking India’s Health Models: From Tax Relief to True Reform
Mr. Sanjaya Mariwala highlights that India’s recent GST reforms—exempting consultations, diagnostics, and telemedicine—mark a pivotal shift towards affordable, accessible healthcare. By reducing tax burdens on nutraceuticals, the government is positioning preventive nutrition as a mainstream practice. However, he notes, to truly transform healthcare, India must invest in workforce skilling, infrastructure, and trust-building. The future of Indian healthcare lies in integrating digital health, preventive care, and evidence-based wellness models.
India’s Compliance Burden and the Future of Labour Reform ft Sanjaya Mariwala
In The Core Report Special Edition, Sanjaya Mariwala discusses India’s compliance overload, labour code reforms, and how regulatory clarity can unlock manufacturing growth and competitiveness.
India’s Manufacturing Transformation ft Sanjaya Mariwala
Delighted to join the CII Podcast, where Mr. Sanjaya Mariwala discussed with Jayant Sriram how India can scale manufacturing and drive inclusive global growth. Topics included transforming skills, capital, regulations, and technology, boosting MSMEs, and unlocking the global potential of India’s nutraceutical sector.
Decoding India’s Nutraceutical Industry ft. Sanjaya Mariwala
Mr. Sanjaya Mariwala had a delightful conversation with Aleem Merchant on the Two Pills in a Pod podcast, discussing trends shaping healthcare and pharma, along with insights from my journey in business and leadership.
Consumption और Demand से कैसे सुधरेगी GDP
Indian industries are set to benefit from the recent budget announcements, especially through income tax adjustments and a focus on consumer-oriented growth. In conversation with Abdullah Arif, Mr. Sanjaya Mariwala shared insights on how these measures will drive consumption, corporate investment, and job creation. We also discussed initiatives like the #investment index, the shift towards local raw materials for manufacturing, and enhanced ease of doing business. As India positions itself in the global supply chain and navigates geopolitical opportunities, the budget is paving the way for a more robust, competitive economy.
EP – NutrifyToday Boardroom Series
Mr. Sanjaya Mariwala, Executive Chairman and Managing Director of OmniActive Health Technologies, shared his insights on the evolving landscape of India’s nutraceutical industry. He emphasizes the critical role of branded ingredients in enhancing consumer trust and driving market growth. Additionally, he highlights the importance of regulatory advancements and consumer education in shaping the future of dietary supplements in India.
ET Now Swadesh
Mr. Sanjaya Mariwala shared his thoughts on how corporate-farmer partnerships might boost agricultural yields and revenue while also helping businesses. Through his innovative techniques, Mr. Mariwala has significantly raised the standard of living for farmers in some parts of the country.
Agriculture Today Group
A strong voice in the nutraceuticals industry, Mr. Sanjaya Mariwala highlighted various market trends and delved deep into the reasons that motivated Omniactive to engage in the production of their proprietary hybrid seeds, rather than being overly dependent on substantial imports.
West Asia shadow on exports
The article highlights the challenges arising for the pharmaceutical and preventive healthcare sector due to the West Asia crisis, particularly through disruptions in trade routes, rising logistics and freight costs, shipment delays, and uncertainty in exports. It further underscores the need for resilient supply chains, diversification of export markets, alternative shipping strategies, and stronger policy support to help the sector navigate geopolitical and trade-related disruptions.
West Asia Crisis Puts India’s Pharma and Preventive Healthcare Exports to the Test
This opinion piece examines how the West Asia crisis is testing India’s pharmaceutical and preventive healthcare exports through rising freight costs, supply chain disruptions, shipment delays, and trade uncertainties. It further discusses the need for resilient supply chains, diversified sourcing strategies, alternative trade routes, and stronger policy support to help the sector manage geopolitical disruptions and sustain export competitiveness in global markets.
India’s policy needs execution, not mere formulation
This opinion piece examines the challenges facing India’s nutraceutical sector, particularly gaps in categorisation, approval timelines, and scientific infrastructure. It further outlines recommendations such as evidence-based claim categorisation, introduction of a credible “Nutra Mark” certification, and clearer regulatory ownership between FSSAI and CDSCO. The piece also stresses the importance of stronger scientific infrastructure and strategic export planning to accelerate sectoral growth.
Sustainable sourcing for nutraceuticals: Creating enduring systems
The featured article explores the best practices of sustainable sourcing in the nutraceutical sector and at OmniActive Health Technologies as demand for natural ingredients continues to rise. It emphasizes responsible cultivation, efficient resource utilization, stronger farmer collaboration, and scientific validation to build resilient supply chains. The piece further underlines how sustainability is moving beyond compliance to become integral to nutraceutical innovation and long-term industry growth.
India-US deal brings relief to nutraceutical exports after customers cut orders and inventories
The interim India-US trade deal lowers tariffs, restores exporter confidence, and emphasises policy clarity and stable frameworks to revive nutraceutical orders and enable long-term investment planning.
From Budget Vision to Manufacturing Momentum
The article explores how policy direction must translate into on-ground manufacturing strength, urging sharper execution, innovation focus, and industry-government alignment to unlock India’s growth potential.
Speaking Engagements
Nutrify C-Suite Sumflex, 2024
Vitafoods India, 2024
IMCs Bharath Calling Conference 2026
